These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Interacting effects of the dopamine transporter gene and psychosocial adversity on attention-deficit/hyperactivity disorder symptoms among 15-year-olds from a high-risk community sample. Laucht M; Skowronek MH; Becker K; Schmidt MH; Esser G; Schulze TG; Rietschel M Arch Gen Psychiatry; 2007 May; 64(5):585-90. PubMed ID: 17485610 [TBL] [Abstract][Full Text] [Related]
4. A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD). Sharma A; Couture J Ann Pharmacother; 2014 Feb; 48(2):209-25. PubMed ID: 24259638 [TBL] [Abstract][Full Text] [Related]
5. Attention-deficit/hyperactivity disorder and the dopaminergic hypotheses. Genro JP; Kieling C; Rohde LA; Hutz MH Expert Rev Neurother; 2010 Apr; 10(4):587-601. PubMed ID: 20367210 [TBL] [Abstract][Full Text] [Related]
6. Background, clinical features and treatment of attention deficit hyperactivity disorder in children. Warikoo N; Faraone SV Expert Opin Pharmacother; 2013 Oct; 14(14):1885-906. PubMed ID: 23865438 [TBL] [Abstract][Full Text] [Related]
7. Catecholamine dysfunction in attention-deficit/hyperactivity disorder: an update. Prince J J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S39-45. PubMed ID: 18480676 [TBL] [Abstract][Full Text] [Related]
9. [Alterations in the pattern of dopaminergic markers in attention-deficit/hyperactivity disorder]. Díaz-Heijtz R; Mulas F; Forssberg H Rev Neurol; 2006 Feb; 42 Suppl 2():S19-23. PubMed ID: 16555214 [TBL] [Abstract][Full Text] [Related]
10. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder. Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622 [TBL] [Abstract][Full Text] [Related]
11. Attention-deficit disorders and epilepsy in childhood: incidence, causative relations and treatment possibilities. Kaufmann R; Goldberg-Stern H; Shuper A J Child Neurol; 2009 Jun; 24(6):727-33. PubMed ID: 19491115 [TBL] [Abstract][Full Text] [Related]
12. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder. Foy JM; Earls MF Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972 [TBL] [Abstract][Full Text] [Related]
15. Attention-deficit-hyperactivity disorder: an update. Dopheide JA; Pliszka SR Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419 [TBL] [Abstract][Full Text] [Related]
16. [Neurobiology of attention deficit/hyperactivity disorder]. Purper-Ouakil D; Lepagnol-Bestel AM; Grosbellet E; Gorwood P; Simonneau M Med Sci (Paris); 2010 May; 26(5):487-96. PubMed ID: 20510147 [TBL] [Abstract][Full Text] [Related]
17. Attention-deficit/hyperactivity disorder: an update. Pary R; Lewis S; Matuschka PR; Lippmann S South Med J; 2002 Jul; 95(7):743-9. PubMed ID: 12144081 [TBL] [Abstract][Full Text] [Related]
18. Complementary and alternative medical therapies for children with attention-deficit/hyperactivity disorder (ADHD). Pellow J; Solomon EM; Barnard CN Altern Med Rev; 2011 Dec; 16(4):323-37. PubMed ID: 22214252 [TBL] [Abstract][Full Text] [Related]
19. Addressing the lack of studies in attention-deficit/hyperactivity disorder in adults. Ramos-Quiroga JA; Nasillo V; Fernández-Aranda F; Casas M Expert Rev Neurother; 2014 May; 14(5):553-67. PubMed ID: 24738746 [TBL] [Abstract][Full Text] [Related]
20. Lead and Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms: a meta-analysis. Goodlad JK; Marcus DK; Fulton JJ Clin Psychol Rev; 2013 Apr; 33(3):417-25. PubMed ID: 23419800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]